Clinical Trial Update: Study of VI-0521 Compared to Placebo in Treatment of Diabetes and Obesity in Adults With Obesity-Related Co-Morbid Conditions [Phase 3]

View source ↗

Summary

Phase 3 study VI-0521 versus placebo in adults with obesity and obesity-related comorbid conditions completed; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• VI-0521

Snippet

Sponsor: VIVUS LLC | Conditions: Obesity, Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2012-09-06